A Unique Case of Intracranial Amelanotic Melanoma with BRAF V600E Mutation Successfully Treated via Molecular-targeted Therapy-Reference-Cited by-同舟云学术

A Unique Case of Intracranial Amelanotic Melanoma with BRAF V600E Mutation Successfully Treated via Molecular-targeted Therapy

Published:2023-12-31 Issue:0 Volume:10 Page:67-73
ISSN:2188-4226
Container-title:NMC Case Report Journal
language:en
Short-container-title:

Author:

FUJITA Juntaro¹,TOMITA Yusuke¹,ICHIMURA Koichi²,YAMASAKI Rie²,NISHIGAKI Shohei¹,NITTA Yuki¹,INOUE Yusuke¹,SOTOME Yuta¹,KIDANI Naoya¹,MURAOKA Kenichiro¹,HIROTSUNE Nobuyuki¹,NISHINO Shigeki¹

Affiliation:

1. Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital

2. Department of Diagnostic Pathology, Hiroshima City Hiroshima Citizens Hospital

Publisher

Japan Neurosurgical Society

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/nmccrj/10/0/10_2022-0227/_pdf

Reference17 articles.

1. 1) Anonymous: Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo) 57: 9-102, 2017

2. 2) Sloan AE, Nock CJ, Einstein DB: Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16: 248-255, 2009

3. 3) Sperduto PW, Jiang W, Brown PD, et al.: Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (melanoma-molGPA). Int J Radiat Oncol Biol Phys 99: 812-816, 2017

4. 4) Saiag P, Robert C, Grob JJ, et al.: Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: an open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib. Eur J Cancer 154: 57-65, 2021

5. 5) Jaimes N, Braun RP, Thomas L, Marghoob AA: Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype. J Eur Acad Dermatol Venereol 26: 591-596, 2012